Employer record · San Francisco, CA · FY2020–FY2026

Nektar Therapeutics

    Certified LCAs
    5
    FY2024–FY2026
    USCIS approvals
    4
    0 new employment
    Denial rate
    0.0%
    FY2024–FY2026
    Median wage offered
    $175k
    certified LCAs

    Jobs not indexed yet

    Does Nektar Therapeutics sponsor H-1B visas?

    Yes — by its record, Nektar Therapeutics is a small-scale H-1B sponsor: it filed 5 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 4 USCIS H-1B petition approvals (0 for new employment). Its latest certified LCA in our data was decided Aug 24, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Updated · DOL OFLC LCA disclosure + USCIS H-1B Employer Data Hub

    Filings by fiscal year

    Certified LCAs per U.S. government fiscal year (Oct–Sep) — 48 since FY2020; the slim bar is USCIS petition approvals (new + continuing), the bottom row their approval rate.

    Nektar Therapeutics certified LCAs by fiscal year
    Fiscal yearcertified LCAsUSCIS approvalsApproval rate
    FY20128100%
    FY21141292%
    FY22141192%
    FY233267%
    FY2411100%
    FY2522100%
    FY2621100%

    Occupations sponsored

    Occupation (SOC)LCAsMedian wage
    Statisticians 15-20414$177k
    Chemists 19-20311$114k

    Most-filed job titles

    1. Sr. Clinical Data Management Specialist2$177k
    2. Associate Director, Biologics Analytical Development1$114k
    3. Director, Biostatistics1$217k
    4. Principal Biostatistician1$155k

    LCAs per title and median wage offered.

    Where the jobs were

    1. California4 LCAs
    2. Alabama1 LCAs

    We haven't indexed Nektar Therapeutics' jobs yet

    We read jobs straight from employers' own career sites and haven't added Nektar Therapeutics' yet. Its H-1B record on this page comes from public DOL and USCIS data and is not affected.

    Also filed as

    • NEKTAR THERAPEUTICS (USCIS)
    • Nektar Therapeutics (LCA)

    Nektar Therapeutics H-1B: questions people ask

    Does Nektar Therapeutics sponsor H-1B visas?

    Yes — by its record, Nektar Therapeutics is a small-scale H-1B sponsor: it filed 5 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 4 USCIS H-1B petition approvals (0 for new employment). Its latest certified LCA in our data was decided Aug 24, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Is Nektar Therapeutics still sponsoring H-1B in 2026?

    Nektar Therapeutics had 2 certified LCAs in FY2026 (Oct 2025–Sep 2026), about the same as the 2 in FY2025. The latest one in our data was decided Aug 24, 2026. An LCA is filed before a petition, so it shows recent intent to hire on H-1B, not a hire.

    How many H-1B petitions does Nektar Therapeutics get approved?

    USCIS recorded 4 approvals (0 for new employment, the rest continuing employment such as extensions and transfers) and 0 denials for Nektar Therapeutics in FY2024–FY2026 — a denial rate of 0.0%. Source: USCIS H-1B Employer Data Hub (first decisions).

    What is the H-1B salary at Nektar Therapeutics?

    The median wage offered on Nektar Therapeutics's certified LCAs in FY2024–FY2026 was $175k a year. By job title: Sr. Clinical Data Management Specialist $177k (2 LCAs), Associate Director, Biologics Analytical Development $114k (1 LCAs) and Director, Biostatistics $217k (1 LCAs). LCA wages are the pay the employer attested to; actual pay can be higher.

    Which jobs does Nektar Therapeutics sponsor for H-1B?

    Its certified LCAs in FY2024–FY2026 were mostly for Statisticians (4) and Chemists (1).

    Where are Nektar Therapeutics's H-1B jobs?

    By worksite on its certified LCAs (FY2024–FY2026): California (4) and Alabama (1).

    Is Nektar Therapeutics an H-1B dependent employer?

    No — its recent LCAs do not declare it H-1B dependent.

    Does Nektar Therapeutics have open jobs?

    We read jobs straight from employers' own career sites and haven't added Nektar Therapeutics' yet.